Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BRIM, J&J In Dengue R&D Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

BRIM, J&J In Dengue R&D Alliance

Will research and develop compounds targeted for dengue indications

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BRIM Biotechnology has entered a collaboration and license agreement with Janssen Pharmaceutica, a Johnson & Johnson company, under which the parties will research, develop and commercialize certain compounds identified by Janssen that are targeted for dengue indications.
 
Dr. Haishan Jang, BRIM’s president and chief executive officer, said, “We are extremely excited and enthusiastic about working with Janssen in developing effective treatment for dengue. There is a high unmet medical need in dengue, especially in Asia. With Janssen’s experienced Infectious Diseases team and BRIM’s core competencies in translational sciences and integrated operation management in Asia, we are confident at progressing the compounds toward a high quality affordable drug candidate for Dengue disease.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics